Neuland Laboratories (India) Financial Indicators Patterns

We recommend you to makes use of Neuland Laboratories Limited fundamental analysis to find out if markets are presently mispricing the entity. Strictly speaking this interface allows you to check out available financial ratios of Neuland Laboratories as well as the relationship between them. We found twenty-five available fundamentals for Neuland Laboratories which can be compared to its peers in the industry. To make sure the equity is not overpriced, please verify all Neuland Laboratories Limited fundamentals including its Net Income and the relationship between Total Debt and Number of Employees .

Neuland Laboratories Company Summary

Neuland Laboratories competes with Tata Consultancy, HDFC Bank, HDFC Bank, and ITC. Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients in India and internationally.

Neuland Laboratories Market Capitalization vs Profit Margin

Neuland Laboratories Limited is regarded fifth in market capitalization category among related companies. It is regarded fifth in profit margin category among related companies . The ratio of Market Capitalization to Profit Margin for Neuland Laboratories Limited is about  2,111,111,111 

Neuland Laboratories Market Fundamentals

 Change(%) 0.00%

Distress Rating

Neuland Laboratories Financial Distress Probability

Chance of Financial Distress
Neuland Laboratories Limited has less than 40 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Compare Neuland Laboratories

Compare Neuland Laboratories To Peers

Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Please see also Stocks Correlation. Please also try Companies Directory module to evaluate performance of over 100,000 stocks, funds, and etfs against different fundamentals.